Free Access to TSR Screeners - Sign Up for Your Nightly Pass

Stock Analysis of Jubilant Pharmova Ltd. (JUBLPHARMA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code JUBLPHARMA
Close 994.50
Change -51.10 / 4.89 %
Volume 206206
Vol Change 146511 / 245.43 %
IndustryDrugs & Pharma
SectorHealthcare
TSR Strength Index
Technical StrengthBearish
Growth Index Poor Growth Stock
Value Index Very Low Value Stock
Profitability Index No Significant Profitability
Stability Index Mild Stability


Fundamental View of Jubilant Pharmova Ltd.


Highs/Lows of Jubilant Pharmova Ltd.
PeriodOld priceStock ReturnNifty 50HighLowHigh DateLow Date
One Week1050.505.33 % 0.794 % 1073.00983.6014-Jan-2619-Jan-26
Two Week1070.607.11 % 2.53 % 1107.80983.6007-Jan-2619-Jan-26
One Month1087.108.52 % 1.47 % 1107.80983.6007-Jan-2619-Jan-26
Three Month1079.807.90 % 0.483 % 1184.80983.6021-Oct-2519-Jan-26
Six Months1232.0019.28 % 2.47 % 1248.00983.6030-Jul-2519-Jan-26
One year941.605.62 % 10.27 % 1248.00802.0030-Jul-2507-Apr-25
Two year572.9073.59 % 18.33 % 1309.90532.1507-Nov-2423-Jan-24
Five year981.151.36 % 76.19 % 1309.90268.9007-Nov-2429-Mar-23
Ten year326.65204.45 % 244.12 % 1309.90234.3507-Nov-2430-Mar-20


Technical View of Jubilant Pharmova Ltd.






Charts of Jubilant Pharmova Ltd.


Returns of Jubilant Pharmova Ltd. with Peers
Period / StockJUBLPHARMANEULANDLABCOHANCENATCOPHARMAGARWALEYE
1 Week-5.33%-5.48%-8.69%-1.41%-4.11%
1 Mth-8.52%-13.37%-22.43%-7.74%-4.25%
3 Mth-7.90%-14.63%-53.07%2.37%-12.09%
6mth-19.28%-2.55%-61.45%-18.29%9.53%
1 Year5.62%1.82%-61.31%-31.77%-
2 Year73.59%135.11%-39.19%1.27%-
5 Years1.36%904.12%-14.50%-7.12%-
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Jubilant Pharmova Ltd. with Peers
Ratio / StockJUBLPHARMANEULANDLABCOHANCENATCOPHARMAGARWALEYE
PE32.9074.6648.279.84129.63
P/B2.5412.025.131.988.27
ROA3.8011.147.4417.413.20
ROE7.7116.1011.1220.166.61
Debt To Equity0.3980.0910.0650.03610.166
Revenue72345.00 M
7.93 %
14768.40 M
5.24 %
11975.80 M
13.91 %
44295.00 M
10.77 %
17110.00 M
28.44 %
Net Income8394.00 M
988.72 %
2601.10 M
13.32 %
2678.70 M
10.79 %
18854.00 M
35.81 %
834599 K
0.482 %


Technicals of Jubilant Pharmova Ltd. with Peers
Technical / StockJUBLPHARMANEULANDLABCOHANCENATCOPHARMAGARWALEYE-
ADX19.6122.8065.5717.1210.94
CMF0.0108-0.273-0.409-0.233-0.196
MFI44.1427.030.63457.5336.99
RSI34.3430.839.9139.9934.67
MACD Abv SignalFalseFalseFalseFalseFalse
Price Above 50 MAFalseFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalseTrue-


About : Jubilant Pharmova Limited


Address : 1A, Sector 16A, Noida, India, 201301
Tel : 91 12 0436 1000
URL : https://www.jubilantpharmova.com
Code : JUBLPHARMA, ISIN : INE700A01033, Exchange : NSE, Country : India
Fiscal Year End : March
Employee Count : 5547

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Quick Overview of Birds Eye View